SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-043842
Filing Date
2024-04-11
Accepted
2024-04-11 21:10:41
Documents
1
Period of Report
2023-12-14

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 4616
  Complete submission text file 0000950170-24-043842.txt   6224
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Issuer) CIK: 0001971543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MURAL ONCOLOGY LTD. 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address
Loew Caroline (Reporting) CIK: 0001989488 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41837 | Film No.: 24839817